NCT00111319
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Investigative Clinical Research of Indiana, LLC Indianapolis, Indiana, United States
Clinical trial condition
Hematologic Diseases
Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.
15,374 public trials
2,843 recruiting studies
Hematologic Diseases trial results
NCT00117117
- Conditions
- Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases
- Locations
-
Not specified
NCT00120705
- Conditions
- Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
- Locations
-
Not specified
NCT00115375
- Conditions
- Blood Platelet Disorders, Cardiovascular Abnormalities, Cardiovascular Diseases, +10 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office Diegem, Belgium
- Sanofi-Aventis Administrative Office Laval, Canada
- Sanofi-Aventis Administrative Office Paris, France
NCT00064584
- Conditions
- Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- UCLA Medical Center Los Angeles, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Ohio State University Medical Center Columbus, Ohio, United States
Completed
Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia
NCT00866073
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany
- Klinikum der Technischen Universität Aachen Aachen, Germany
- Universitätsklinikum Düsseldorf Düsseldorf, Germany
- Katholisches Krankenhaus Hagen Hagen, Germany
NCT00120237
- Conditions
- Anemia, Female Urogenital Diseases and Pregnancy Complications, Hematologic Diseases, +10 more
- Locations
-
- Home delivery setting Chitral, Chitral District, Pakistan
NCT00452257
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Duarte, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States
NCT00355407
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer
NCT00095277
- Conditions
- Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
Not specified